Pediatrix Medical Group announces $250M share repurchase program

* Pediatrix Medical Group (NYSE:MD [https://seekingalpha.com/symbol/MD]) said on Monday that its board has authorized a share repurchase program [https://seekingalpha.com/pr/20204255-pediatrix-medical-group-announces-250-million-share-repurchase-program]of up to $250M of the company’s outstanding common stock.
* “In view of our strong cash flow, current and forecasted cash balances and relatively low debt levels, our board has authorized a $250Mshare repurchase program, which we plan to use opportunistically,” said Mark S. Ordan, Chair of the Board and Chief Executive Officer.
* Pediatrix (NYSE:MD [https://seekingalpha.com/symbol/MD]) shares were up more than 4% in extended trading.

MORE ON PEDIATRIX MEDICAL GROUP

* Pediatrix Medical Group, Inc. (MD) Q2 2025 Earnings Call Transcript [https://seekingalpha.com/article/4808766-pediatrix-medical-group-inc-md-q2-2025-earnings-call-transcript]
* Pediatrix raises 2025 adjusted EBITDA guidance to $245M–$255M as NICU days climb 6% and cash flow strengthens [https://seekingalpha.com/news/4478609-pediatrix-raises-2025-adjusted-ebitda-guidance-to-245m-255m-as-nicu-days-climb-6-percent-and]
* Pediatrix Medical Group Q2 2025 Earnings Preview [https://seekingalpha.com/news/4477385-pediatrix-medical-group-q2-2025-earnings-preview]
* Seeking Alpha’s Quant Rating on Pediatrix Medical Group [https://seekingalpha.com/symbol/MD/ratings/quant-ratings]
* Historical earnings data for Pediatrix Medical Group [https://seekingalpha.com/symbol/MD/earnings]